Published :
Updated :
For all latest news, follow The Financial Express Google News channel.
Homegrown drug maker Delta Life Sciences PLC plans to manufacture specialised drugs to meet the growing local and global demand from its proposed plant at the National Special Economic Zone (NSEZ) in Chattogram. The company is set to invest around $30 million in the project which would generate approximately 700 direct jobs. To this effect, the company inked a land lease agreement with the Bangladesh Economic Zones Authority (BEZA) for the allocation of 30 acres of land.
In the presence of BEZA Executive Chairman Chowdhury Ashik Mahmud Bin Harun, BEZA Executive Member (Investment Promotion) Saleh Ahmed and Managing Director of Delta Life Sciences Dr Md Zakir Hossain inked the agreement on behalf of their respective sides at the BEZA headquarters in the city's Agargaon area on Wednesday.
Speaking at the event, Ashik Chowdhury congratulated the investors, noting that the NSEZ has created a unique opportunity for investors. "This pharmaceutical investment would diversify production and take Bangladesh's pharmaceutical industry to new heights of global competitiveness," he said. He expressed the hope that such investments would play a vital role in creating jobs and boosting exports. Pharmaceutical is one of the key thrust sectors getting priority for investment, he said.
In his speech, Mr Zakir Hossain said their goal is to establish Bangladesh as a regional hub for advanced pharmaceutical production and research. By building modern production facilities at the NSEZ, the company aims to meet local demand while supplying competitive products to global markets.
He added that the investment would not only strengthen Bangladesh's healthcare sector but also contribute significantly to foreign currency earnings. Responding to queries, he said the company hopes to begin production within the next three years, initially focusing on oral solid and oncology medicines.
As per the investment proposal, the plant would comprise biopharmaceutical fill-finish and formulation facility, oncology (injectable and oral solid dosage form) facility, herbal, nutraceutical, and natural medicine facility, active pharmaceutical ingredient (api) manufacturing facility, manufacturing facility with artificial intelligence (AI), and Research & Development (R&D) Centre.
saif.febd@gmail.com